Dynamic42 receives Thüringer Gründerpreis 2018

7. December 2018 In News

Thuringian Founder’s Award – Dynamic42 GmbH honoured

On 04 December 2018, this year’s Thuringian Founder’s Prize was awarded in the historic Volksbad Jena. Dynamic42 GmbH was awarded 3rd place in category 1 “Business Plan”. The prize, endowed with €5,000, was presented by Thuringia’s Minister of Economic Affairs Wolfgang Tiefensee. “We are very happy to have received an early Christmas present. It seemed to have been a neck-and-neck race in the business plan category, as we heard from the IHK. All the nicer that we made it onto the winner’s podium,” says Dr. Knut Rennert, Managing Director of Dynamic42 GmbH. The Thuringian Ministry of Economy, Science and Digital Society (TMWWDG) provided a total of 75,000 € in prize money and the IHK Ostthüringen zu Gera and the Thuringian Centre for Start-ups and Entrepreneurship (ThEx) selected 11 winners from 69 applications in 4 categories.

We would like to thank all participants for a great competition and especially Ms Beate Seifarth (IHK) for the good organisation and support!

The complete award ceremony can be viewed here on Facebook.

Cancer, rheumatism, asthma: organ-on-chip models highly relevant for preclinical testing of therapeutic antibodies

Improving people's lives with innovative technologies. This was the goal that Jena-based Dynamic42 had in mind 18 months ago when they launched a project - funded as part of the Sanofi iDEA-iTECH Award Program.

ATHANA alliance for antifungal therapy approaches – First strategy workshop

The RUBIN alliance “ATHANA” met for their first strategy workshop one year after the project kicked off in summer last year.

Amélie Marie Paillereau joins Dynamic42 as Master Student funded by the Thuringia and European Social Fund Plus

We are excited to welcome Amélie Marie Paillereau to the Dynamic42 science team. Amélie started in April with us for a 12-month-long Master thesis, focusing on perfused breast and pancreatic cancer-on-chip models to study the impact of the tumor microenvironment on immune cell invasion.

All News